Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency

Cell

Volumn 165, Issue 7, 2016, Pages 1609-1620

  Bournazos, Stylianos ^a   Gazumyan, Anna ^a   Seaman, Michael S ^b   Nussenzweig, Michel C ^a   Ravetch, Jeffrey V ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBODY; BISPECIFIC ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G3 ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN ANTIBODY; EPITOPE; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; CRYSTAL STRUCTURE; DRUG POTENCY; DRUG POTENTIATION; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PASSIVE IMMUNIZATION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODIES, NEUTRALIZING; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MICE;

EID: 84975270914     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.04.050     Document Type: Article

References (52)

1. M. Asokan, R.S. Rudicell, M. Louder, K. McKee, S. O'Dell, G. Stewart-Jones, K. Wang, L. Xu, X. Chen, M. Choe, and et al. Bispecific antibodies targeting different epitopes on the HIV-1 envelope exhibit broad and potent neutralization J. Virol. 89 2015 12501 12512
2. D.H. Barouch, J.B. Whitney, B. Moldt, F. Klein, T.Y. Oliveira, J. Liu, K.E. Stephenson, H.W. Chang, K. Shekhar, S. Gupta, and et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys Nature 503 2013 224 228
3. C. Blattner, J.H. Lee, K. Sliepen, R. Derking, E. Falkowska, A.T. de la Peña, A. Cupo, J.P. Julien, M. van Gils, P.S. Lee, and et al. Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers Immunity 40 2014 669 680
4. S. Bournazos, and J.V. Ravetch Fcγ receptor pathways during active and passive immunization Immunol. Rev. 268 2015 88 103
5. S. Bournazos, F. Klein, J. Pietzsch, M.S. Seaman, M.C. Nussenzweig, and J.V. Ravetch Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity Cell 158 2014 1243 1253
6. S. Bournazos, D.J. DiLillo, and J.V. Ravetch The role of Fc-FcγR interactions in IgG-mediated microbial neutralization J. Exp. Med. 212 2015 1361 1369
7. D.R. Burton, and J.R. Mascola Antibody responses to envelope glycoproteins in HIV-1 infection Nat. Immunol. 16 2015 571 576
8. M. Caskey, F. Klein, J.C. Lorenzi, M.S. Seaman, A.P. West Jr., N. Buckley, G. Kremer, L. Nogueira, M. Braunschweig, J.F. Scheid, and et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 Nature 522 2015 487 491
9. P. Chames, and D. Baty Bispecific antibodies for cancer therapy: the light at the end of the tunnel? MAbs 1 2009 539 547
10. R. Derking, G. Ozorowski, K. Sliepen, A. Yasmeen, A. Cupo, J.L. Torres, J.P. Julien, J.H. Lee, T. van Montfort, S.W. de Taeye, and et al. Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer PLoS Pathog. 11 2015 e1004767
11. R. Diskin, F. Klein, J.A. Horwitz, A. Halper-Stromberg, D.N. Sather, P.M. Marcovecchio, T. Lee, A.P. West Jr., H. Gao, M.S. Seaman, and et al. Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies J. Exp. Med. 210 2013 1235 1249
12. R.P. Galimidi, J.S. Klein, M.S. Politzer, S. Bai, M.S. Seaman, M.C. Nussenzweig, A.P. West Jr., and P.J. Bjorkman Intra-spike crosslinking overcomes antibody evasion by HIV-1 Cell 160 2015 433 446
13. N.L. Haigwood, D.C. Montefiori, W.F. Sutton, J. McClure, A.J. Watson, G. Voss, V.M. Hirsch, B.A. Richardson, N.L. Letvin, S.L. Hu, and P.R. Johnson Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies J. Virol. 78 2004 5983 5995
14. A. Halper-Stromberg, C.L. Lu, F. Klein, J.A. Horwitz, S. Bournazos, L. Nogueira, T.R. Eisenreich, C. Liu, A. Gazumyan, U. Schaefer, and et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice Cell 158 2014 989 999
15. A.J. Hessell, L. Hangartner, M. Hunter, C.E. Havenith, F.J. Beurskens, J.M. Bakker, C.M. Lanigan, G. Landucci, D.N. Forthal, P.W. Parren, and et al. Fc receptor but not complement binding is important in antibody protection against HIV Nature 449 2007 101 104
16. J.A. Horwitz, A. Halper-Stromberg, H. Mouquet, A.D. Gitlin, A. Tretiakova, T.R. Eisenreich, M. Malbec, S. Gravemann, E. Billerbeck, M. Dorner, and et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice Proc. Natl. Acad. Sci. USA 110 2013 16538 16543
17. J. Huang, G. Ofek, L. Laub, M.K. Louder, N.A. Doria-Rose, N.S. Longo, H. Imamichi, R.T. Bailer, B. Chakrabarti, S.K. Sharma, and et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Nature 491 2012 406 412
18. J. Huang, B.H. Kang, M. Pancera, J.H. Lee, T. Tong, Y. Feng, H. Imamichi, I.S. Georgiev, G.Y. Chuang, A. Druz, and et al. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface Nature 515 2014 138 142
19. J.P. Julien, D. Sok, R. Khayat, J.H. Lee, K.J. Doores, L.M. Walker, A. Ramos, D.C. Diwanji, R. Pejchal, A. Cupo, and et al. Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans PLoS Pathog. 9 2013 e1003342
20. J.S. Klein, and P.J. Bjorkman Few and far between: how HIV may be evading antibody avidity PLoS Pathog. 6 2010 e1000908
21. J.S. Klein, P.N. Gnanapragasam, R.P. Galimidi, C.P. Foglesong, A.P. West Jr., and P.J. Bjorkman Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10 Proc. Natl. Acad. Sci. USA 106 2009 7385 7390
22. F. Klein, C. Gaebler, H. Mouquet, D.N. Sather, C. Lehmann, J.F. Scheid, Z. Kraft, Y. Liu, J. Pietzsch, A. Hurley, and et al. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein J. Exp. Med. 209 2012 1469 1479
23. F. Klein, A. Halper-Stromberg, J.A. Horwitz, H. Gruell, J.F. Scheid, S. Bournazos, H. Mouquet, L.A. Spatz, R. Diskin, A. Abadir, and et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice Nature 492 2012 118 122
24. F. Klein, H. Mouquet, P. Dosenovic, J.F. Scheid, L. Scharf, and M.C. Nussenzweig Antibodies in HIV-1 vaccine development and therapy Science 341 2013 1199 1204
25. L. Kong, J.H. Lee, K.J. Doores, C.D. Murin, J.P. Julien, R. McBride, Y. Liu, A. Marozsan, A. Cupo, P.J. Klasse, and et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 Nat. Struct. Mol. Biol. 20 2013 796 803
26. R. Kong, M.K. Louder, K. Wagh, R.T. Bailer, A. deCamp, K. Greene, H. Gao, J.D. Taft, A. Gazumyan, C. Liu, and et al. Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes J. Virol. 89 2015 2659 2671
27. J.H. Lee, D.P. Leaman, A.S. Kim, A. Torrents de la Peña, K. Sliepen, A. Yasmeen, R. Derking, A. Ramos, S.W. de Taeye, G. Ozorowski, and et al. Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike Nat. Commun. 6 2015 8167
28. H.X. Liao, R. Lynch, T. Zhou, F. Gao, S.M. Alam, S.D. Boyd, A.Z. Fire, K.M. Roskin, C.A. Schramm, Z. Zhang, et al. NISC Comparative Sequencing Program Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Nature 496 2013 469 476
29. R.M. Lynch, E. Boritz, E.E. Coates, A. DeZure, P. Madden, P. Costner, M.E. Enama, S. Plummer, L. Holman, C.S. Hendel, et al. VRC 601 Study Team Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection Sci. Transl. Med. 7 2015 319ra206
30. A.M. Merchant, Z. Zhu, J.Q. Yuan, A. Goddard, C.W. Adams, L.G. Presta, and P. Carter An efficient route to human bispecific IgG Nat. Biotechnol. 16 1998 677 681
31. D.C. Montefiori Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays Curr. Protoc. Immunol. 12 2005 Unit 12.11
32. H. Mouquet, L. Scharf, Z. Euler, Y. Liu, C. Eden, J.F. Scheid, A. Halper-Stromberg, P.N. Gnanapragasam, D.I. Spencer, M.S. Seaman, and et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies Proc. Natl. Acad. Sci. USA 109 2012 E3268 E3277
33. C.T. Ng, J.P. Jaworski, P. Jayaraman, W.F. Sutton, P. Delio, L. Kuller, D. Anderson, G. Landucci, B.A. Richardson, D.R. Burton, and et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques Nat. Med. 16 2010 1117 1119
34. C.S. Pace, R. Song, C. Ochsenbauer, C.D. Andrews, D. Franco, J. Yu, D.A. Oren, M.S. Seaman, and D.D. Ho Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1 Proc. Natl. Acad. Sci. USA 110 2013 13540 13545
35. A. Pegu, M. Asokan, L. Wu, K. Wang, J. Hataye, J.P. Casazza, X. Guo, W. Shi, I. Georgiev, T. Zhou, and et al. Activation and lysis of human CD4 cells latently infected with HIV-1 Nat. Commun. 6 2015 8447
36. R. Pejchal, K.J. Doores, L.M. Walker, R. Khayat, P.S. Huang, S.K. Wang, R.L. Stanfield, J.P. Julien, A. Ramos, M. Crispin, and et al. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Science 334 2011 1097 1103
37. J. Pietzsch, H. Gruell, S. Bournazos, B.M. Donovan, F. Klein, R. Diskin, M.S. Seaman, P.J. Bjorkman, J.V. Ravetch, A. Ploss, and M.C. Nussenzweig A mouse model for HIV-1 entry Proc. Natl. Acad. Sci. USA 109 2012 15859 15864
38. J.B. Ridgway, L.G. Presta, and P. Carter 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization Protein Eng. 9 1996 617 621
39. K.H. Roux, L. Strelets, and T.E. Michaelsen Flexibility of human IgG subclasses J. Immunol. 159 1997 3372 3382
40. K.H. Roux, L. Strelets, O.H. Brekke, I. Sandlie, and T.E. Michaelsen Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry J. Immunol. 161 1998 4083 4090
41. W. Schaefer, J.T. Regula, M. Bähner, J. Schanzer, R. Croasdale, H. Dürr, C. Gassner, G. Georges, H. Kettenberger, S. Imhof-Jung, and et al. Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies Proc. Natl. Acad. Sci. USA 108 2011 11187 11192
42. L. Scharf, H. Wang, H. Gao, S. Chen, A.W. McDowall, and P.J. Bjorkman Broadly neutralizing antibody 8ANC195 recognizes closed and open states of HIV-1 Env Cell 162 2015 1379 1390
43. J.F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T.Y. Oliveira, J. Pietzsch, D. Fenyo, A. Abadir, K. Velinzon, and et al. Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding Science 333 2011 1633 1637
44. M. Shingai, Y. Nishimura, F. Klein, H. Mouquet, O.K. Donau, R. Plishka, A. Buckler-White, M. Seaman, M. Piatak Jr., J.D. Lifson, and et al. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia Nature 503 2013 277 280
45. D. Sok, M.J. van Gils, M. Pauthner, J.P. Julien, K.L. Saye-Francisco, J. Hsueh, B. Briney, J.H. Lee, K.M. Le, P.S. Lee, and et al. Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex Proc. Natl. Acad. Sci. USA 111 2014 17624 17629
46. C. Spiess, Q. Zhai, and P.J. Carter Alternative molecular formats and therapeutic applications for bispecific antibodies Mol. Immunol. 67 2 Pt A 2015 95 106
47. J.A. Sung, J. Pickeral, L. Liu, S.A. Stanfield-Oakley, C.Y. Lam, C. Garrido, J. Pollara, C. LaBranche, M. Bonsignori, M.A. Moody, and et al. Dual-affinity re-targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells J. Clin. Invest. 125 2015 4077 4090
48. L.M. Walker, S.K. Phogat, P.Y. Chan-Hui, D. Wagner, P. Phung, J.L. Goss, T. Wrin, M.D. Simek, S. Fling, J.L. Mitcham, et al. Protocol G Principal Investigators Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target Science 326 2009 285 289
49. L.M. Walker, M. Huber, K.J. Doores, E. Falkowska, R. Pejchal, J.P. Julien, S.K. Wang, A. Ramos, P.Y. Chan-Hui, M. Moyle, et al. Protocol G Principal Investigators Broad neutralization coverage of HIV by multiple highly potent antibodies Nature 477 2011 466 470
50. A.B. Ward, and I.A. Wilson Insights into the trimeric HIV-1 envelope glycoprotein structure Trends Biochem. Sci. 40 2015 101 107
51. T. Zhou, R.M. Lynch, L. Chen, P. Acharya, X. Wu, N.A. Doria-Rose, M.G. Joyce, D. Lingwood, C. Soto, R.T. Bailer, et al. NISC Comparative Sequencing Program Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors Cell 161 2015 1280 1292
52. P. Zhu, J. Liu, J. Bess Jr., E. Chertova, J.D. Lifson, H. Grisé, G.A. Ofek, K.A. Taylor, and K.H. Roux Distribution and three-dimensional structure of AIDS virus envelope spikes Nature 441 2006 847 852